カテゴリ： 世界, 医療/バイオ, QYResearch

ADHD治療薬の世界市場2023年：刺激薬、非刺激薬

■ 英語タイトル：Global ADHD Medication Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8657）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8657
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ADHD治療薬の世界市場2023年：刺激薬、非刺激薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はADHD治療薬のグローバル市場について調査・分析し、世界のADHD治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（刺激薬、非刺激薬）、用途別セグメント分析（注意力欠如障害、多動・衝動制御障害、複合型）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Takeda、Johnson & Johnson、Novartis、Eli Lilly、Tris Pharma, Inc、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、Noven Pharmaceuticals、Purdue Parma、Zhengda Fenghaiなどが含まれています。ADHD治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ADHD治療薬市場規模を算出する際に考慮しました。

・ADHD治療薬市場の概要
- ADHD治療薬の種類別セグメント
- 世界のADHD治療薬市場規模：タイプ別分析（刺激薬、非刺激薬）
- ADHD治療薬の用途別セグメント
- 世界のADHD治療薬市場規模：用途別分析（注意力欠如障害、多動・衝動制御障害、複合型）
- 世界のADHD治療薬市場規模予測（2018年-2029年）

・ADHD治療薬市場の成長トレンド
- ADHD治療薬の地域別市場規模（2018年-2029年）
- ADHD治療薬市場ダイナミクス
- ADHD治療薬の業界動向
- ADHD治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：刺激薬、非刺激薬
- 世界のADHD治療薬のタイプ別市場規模（2018年-2023年）
- 世界のADHD治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：注意力欠如障害、多動・衝動制御障害、複合型
- 世界のADHD治療薬の用途別市場規模（2018年-2023年）
- 世界のADHD治療薬の用途別市場規模（2024年-2029年）

・ADHD治療薬の地域別市場規模
- 北米のADHD治療薬市場規模（2018年-2029年）
- 米国のADHD治療薬市場規模（2018年-2029年）
- ヨーロッパのADHD治療薬市場規模（2018年-2029年）
- アジア太平洋のADHD治療薬市場規模（2018年-2029年）
- 中国のADHD治療薬市場規模（2018年-2029年）
- 日本のADHD治療薬市場規模（2018年-2029年）
- 韓国のADHD治療薬市場規模（2018年-2029年）
- インドのADHD治療薬市場規模（2018年-2029年）
- オーストラリアのADHD治療薬市場規模（2018年-2029年）
- 中南米のADHD治療薬市場規模（2018年-2029年）
- 中東・アフリカのADHD治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Takeda、Johnson & Johnson、Novartis、Eli Lilly、Tris Pharma, Inc、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、Noven Pharmaceuticals、Purdue Parma、Zhengda Fenghai

・アナリストの観点/結論

・調査手法と情報源

Stimulants are the best and most common type of medication used to treat ADHD.
Highlights
The global ADHD Medication market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Johnson & Johnson is the largest manufacturer of ADHD medication in China, has a market share of over 40%. Other key players include Eli Lilly and Zhengda Fenghai, etc. Geographically speaking, East China is the largest market, has a market share of about 25%. In terms of type, both stimulants and non-stimulants account for about 50% of market share. In terms of application, hybrid is the dominant field using ADHD medication, has a market share of over 80%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ADHD Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADHD Medication.
The ADHD Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ADHD Medication market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADHD Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Attention Deficit
Hyperactivity/impulse Control Disorder
Hybrid
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ADHD Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADHD Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global ADHD Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Attention Deficit
1.3.3 Hyperactivity/impulse Control Disorder
1.3.4 Hybrid
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADHD Medication Market Perspective (2018-2029)
2.2 ADHD Medication Growth Trends by Region
2.2.1 Global ADHD Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 ADHD Medication Historic Market Size by Region (2018-2023)
2.2.3 ADHD Medication Forecasted Market Size by Region (2024-2029)
2.3 ADHD Medication Market Dynamics
2.3.1 ADHD Medication Industry Trends
2.3.2 ADHD Medication Market Drivers
2.3.3 ADHD Medication Market Challenges
2.3.4 ADHD Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADHD Medication Players by Revenue
3.1.1 Global Top ADHD Medication Players by Revenue (2018-2023)
3.1.2 Global ADHD Medication Revenue Market Share by Players (2018-2023)
3.2 Global ADHD Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ADHD Medication Revenue
3.4 Global ADHD Medication Market Concentration Ratio
3.4.1 Global ADHD Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADHD Medication Revenue in 2022
3.5 ADHD Medication Key Players Head office and Area Served
3.6 Key Players ADHD Medication Product Solution and Service
3.7 Date of Enter into ADHD Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ADHD Medication Breakdown Data by Type
4.1 Global ADHD Medication Historic Market Size by Type (2018-2023)
4.2 Global ADHD Medication Forecasted Market Size by Type (2024-2029)
5 ADHD Medication Breakdown Data by Application
5.1 Global ADHD Medication Historic Market Size by Application (2018-2023)
5.2 Global ADHD Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America ADHD Medication Market Size (2018-2029)
6.2 North America ADHD Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America ADHD Medication Market Size by Country (2018-2023)
6.4 North America ADHD Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADHD Medication Market Size (2018-2029)
7.2 Europe ADHD Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe ADHD Medication Market Size by Country (2018-2023)
7.4 Europe ADHD Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADHD Medication Market Size (2018-2029)
8.2 Asia-Pacific ADHD Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific ADHD Medication Market Size by Region (2018-2023)
8.4 Asia-Pacific ADHD Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADHD Medication Market Size (2018-2029)
9.2 Latin America ADHD Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America ADHD Medication Market Size by Country (2018-2023)
9.4 Latin America ADHD Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADHD Medication Market Size (2018-2029)
10.2 Middle East & Africa ADHD Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa ADHD Medication Market Size by Country (2018-2023)
10.4 Middle East & Africa ADHD Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda ADHD Medication Introduction
11.1.4 Takeda Revenue in ADHD Medication Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson ADHD Medication Introduction
11.2.4 Johnson & Johnson Revenue in ADHD Medication Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis ADHD Medication Introduction
11.3.4 Novartis Revenue in ADHD Medication Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly ADHD Medication Introduction
11.4.4 Eli Lilly Revenue in ADHD Medication Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma, Inc
11.5.1 Tris Pharma, Inc Company Detail
11.5.2 Tris Pharma, Inc Business Overview
11.5.3 Tris Pharma, Inc ADHD Medication Introduction
11.5.4 Tris Pharma, Inc Revenue in ADHD Medication Business (2018-2023)
11.5.5 Tris Pharma, Inc Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Detail
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics ADHD Medication Introduction
11.6.4 Neos Therapeutics Revenue in ADHD Medication Business (2018-2023)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Detail
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt ADHD Medication Introduction
11.7.4 Mallinckrodt Revenue in ADHD Medication Business (2018-2023)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals ADHD Medication Introduction
11.8.4 Amneal Pharmaceuticals Revenue in ADHD Medication Business (2018-2023)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Detail
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals ADHD Medication Introduction
11.9.4 Noven Pharmaceuticals Revenue in ADHD Medication Business (2018-2023)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Detail
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma ADHD Medication Introduction
11.10.4 Purdue Parma Revenue in ADHD Medication Business (2018-2023)
11.10.5 Purdue Parma Recent Development
11.11 Zhengda Fenghai
11.11.1 Zhengda Fenghai Company Detail
11.11.2 Zhengda Fenghai Business Overview
11.11.3 Zhengda Fenghai ADHD Medication Introduction
11.11.4 Zhengda Fenghai Revenue in ADHD Medication Business (2018-2023)
11.11.5 Zhengda Fenghai Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ADHD Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global ADHD Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global ADHD Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global ADHD Medication Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global ADHD Medication Market Share by Region (2018-2023)
Table 8. Global ADHD Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global ADHD Medication Market Share by Region (2024-2029)
Table 10. ADHD Medication Market Trends
Table 11. ADHD Medication Market Drivers
Table 12. ADHD Medication Market Challenges
Table 13. ADHD Medication Market Restraints
Table 14. Global ADHD Medication Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global ADHD Medication Market Share by Players (2018-2023)
Table 16. Global Top ADHD Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medication as of 2022)
Table 17. Ranking of Global Top ADHD Medication Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by ADHD Medication Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ADHD Medication Product Solution and Service
Table 21. Date of Enter into ADHD Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ADHD Medication Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global ADHD Medication Revenue Market Share by Type (2018-2023)
Table 25. Global ADHD Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global ADHD Medication Revenue Market Share by Type (2024-2029)
Table 27. Global ADHD Medication Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global ADHD Medication Revenue Market Share by Application (2018-2023)
Table 29. Global ADHD Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global ADHD Medication Revenue Market Share by Application (2024-2029)
Table 31. North America ADHD Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America ADHD Medication Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America ADHD Medication Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe ADHD Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe ADHD Medication Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe ADHD Medication Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific ADHD Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific ADHD Medication Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific ADHD Medication Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America ADHD Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America ADHD Medication Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America ADHD Medication Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa ADHD Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa ADHD Medication Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa ADHD Medication Market Size by Country (2024-2029) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda ADHD Medication Product
Table 49. Takeda Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson ADHD Medication Product
Table 54. Johnson & Johnson Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis ADHD Medication Product
Table 59. Novartis Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Eli Lilly Company Detail
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly ADHD Medication Product
Table 64. Eli Lilly Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Tris Pharma, Inc Company Detail
Table 67. Tris Pharma, Inc Business Overview
Table 68. Tris Pharma, Inc ADHD Medication Product
Table 69. Tris Pharma, Inc Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 70. Tris Pharma, Inc Recent Development
Table 71. Neos Therapeutics Company Detail
Table 72. Neos Therapeutics Business Overview
Table 73. Neos Therapeutics ADHD Medication Product
Table 74. Neos Therapeutics Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 75. Neos Therapeutics Recent Development
Table 76. Mallinckrodt Company Detail
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt ADHD Medication Product
Table 79. Mallinckrodt Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 80. Mallinckrodt Recent Development
Table 81. Amneal Pharmaceuticals Company Detail
Table 82. Amneal Pharmaceuticals Business Overview
Table 83. Amneal Pharmaceuticals ADHD Medication Product
Table 84. Amneal Pharmaceuticals Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 85. Amneal Pharmaceuticals Recent Development
Table 86. Noven Pharmaceuticals Company Detail
Table 87. Noven Pharmaceuticals Business Overview
Table 88. Noven Pharmaceuticals ADHD Medication Product
Table 89. Noven Pharmaceuticals Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 90. Noven Pharmaceuticals Recent Development
Table 91. Purdue Parma Company Detail
Table 92. Purdue Parma Business Overview
Table 93. Purdue Parma ADHD Medication Product
Table 94. Purdue Parma Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 95. Purdue Parma Recent Development
Table 96. Zhengda Fenghai Company Detail
Table 97. Zhengda Fenghai Business Overview
Table 98. Zhengda Fenghai ADHD Medication Product
Table 99. Zhengda Fenghai Revenue in ADHD Medication Business (2018-2023) & (US$ Million)
Table 100. Zhengda Fenghai Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ADHD Medication Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global ADHD Medication Market Share by Type: 2022 VS 2029
Figure 3. Stimulant Features
Figure 4. Non-stimulant Features
Figure 5. Global ADHD Medication Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global ADHD Medication Market Share by Application: 2022 VS 2029
Figure 7. Attention Deficit Case Studies
Figure 8. Hyperactivity/impulse Control Disorder Case Studies
Figure 9. Hybrid Case Studies
Figure 10. ADHD Medication Report Years Considered
Figure 11. Global ADHD Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global ADHD Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global ADHD Medication Market Share by Region: 2022 VS 2029
Figure 14. Global ADHD Medication Market Share by Players in 2022
Figure 15. Global Top ADHD Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by ADHD Medication Revenue in 2022
Figure 17. North America ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America ADHD Medication Market Share by Country (2018-2029)
Figure 19. United States ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe ADHD Medication Market Share by Country (2018-2029)
Figure 23. Germany ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific ADHD Medication Market Share by Region (2018-2029)
Figure 31. China ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America ADHD Medication Market Share by Country (2018-2029)
Figure 39. Mexico ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa ADHD Medication Market Share by Country (2018-2029)
Figure 43. Turkey ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia ADHD Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 46. Johnson & Johnson Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 48. Eli Lilly Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 49. Tris Pharma, Inc Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 50. Neos Therapeutics Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 51. Mallinckrodt Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 53. Noven Pharmaceuticals Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 54. Purdue Parma Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 55. Zhengda Fenghai Revenue Growth Rate in ADHD Medication Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 渓谷熱治療薬の世界市場2023年：フルコナゾール、ボリコナゾール、ポサコナゾール、アムホテリシンB、その他
  • 潰瘍性大腸炎治療オプションの世界市場2023年：抗炎症薬、免疫抑制剤、その他医薬品
  • トリメチルアミン尿症治療の世界市場2023年：経口、注射
  • 注意欠陥・多動性症候群治療の世界市場2023年：精神刺激薬、非精神刺激薬
  • 過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：便秘型過敏性腸症候群、下痢型過敏性腸症候群、便秘・下痢型過敏性腸症候群
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8657 )"ADHD治療薬の世界市場2023年：刺激薬、非刺激薬" (英文：Global ADHD Medication Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。